Cause of death, by non-communicable diseases, ages 60+, female in Gambia
Gambia: Cause of death, by non-communicable diseases, ages 60+, female was 65.0% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 60+, female in Gambia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
Gambia recorded 65.0% for cause of death, by non-communicable diseases, ages 60+, female in 2021. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 5.9% on the previous year and down 4.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in Gambia peaked at 71.2% in 2019 and was at its lowest, 65.0%, in 2021.
Gambia ranks 149th of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 60+, female in Gambia, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 68.2% | — |
| 2010 | 68.1% | -0.1% |
| 2015 | 70.4% | +3.3% |
| 2019 | 71.2% | +1.2% |
| 2020 | 69.1% | -3.0% |
| 2021 | 65.0% | -5.9% |
Gambia compared with similar countries
- Gambia's 65.0% is below the median for low income countries, which is 66.3%, 98% of the median. (25 countries reporting)
- Gambia's 65.0% is below the median for Sub-Saharan Africa, which is 66.6%, 98% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 68.2% | 68.2% | 68.2% | 1 |
| 2010s | 69.9% | 68.1% | 71.2% | 3 |
| 2020s | 67.1% | 65.0% | 69.1% | 2 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.9696 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0686 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9636 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in Gambia?
- Cause of death, by non-communicable diseases, ages 60+, female in Gambia was 65.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in Gambia?
- The highest recorded value was 71.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in Gambia?
- The lowest recorded value was 65.0% in 2021.
- How does Gambia rank for cause of death, by non-communicable diseases, ages 60+, female?
- Gambia ranks 149th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in Gambia?
- Over the last ten years it is down 4.6%. The long-run trend across the full record is flat.
- Where does this Gambia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.